No Data
With 71% Institutional Ownership, PureTech Health Plc (LON:PRTC) Is a Favorite Amongst the Big Guns
PureTech Health: Major Shareholder Voting Rights Update
PureTech Health's Seaport Therapeutics Unveils Promising Phase 1 Data for SPT-300
PureTech Founded Entity Seaport Therapeutics Presents Additional Data From Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
PureTech Health Presents Promising Data on LYT-200 for Treating Relapsed Leukemia and Blood Disorders at 2024 ASH Annual Meeting
PureTech Health Strengthens Leadership at Seaport Therapeutics
No Data